Molecular characterization of methicillin-resistant Staphylococcus aureus resistant to tigecycline and daptomycin isolated in a hospital in Brazil

Epidemiology and Infection

Volumn 142, Issue 3, 2014, Pages 479-483

  Dabul, A N G ^a   Camargo, I L B C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibiotic resistance; Bacterial typing; Staphylococcus aureus

Indexed keywords

DALFOPRISTIN; DAPTOMYCIN; LINEZOLID; OXACILLIN; QUINUPRISTIN; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; MECA PROTEIN, STAPHYLOCOCCUS AUREUS; MINOCYCLINE; PENICILLIN BINDING PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BONE INFECTION; BRAZIL; BROTH DILUTION; COMPUTER SYSTEM; CONCENTRATION RESPONSE; ENDEMIC DISEASE; EPSILOMETER TEST; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINE; GENETIC RESISTANCE; GENETIC SIMILARITY; GENOTYPE; HOSPITAL; HUMAN; INCUBATION TIME; INFECTION CONTROL; INTENSIVE CARE UNIT; MEC GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR MECHANICS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRACTICE GUIDELINE; PULSED FIELD GEL ELECTROPHORESIS; SOFT TISSUE INFECTION; STAPHYLOCOCCUS; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; STAPHYLOCOCCUS INFECTION; CLINICAL ARTICLE; MECA GENE; MOLECULAR TYPING;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BRAZIL; DAPTOMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MOLECULAR EPIDEMIOLOGY; PENICILLIN-BINDING PROTEINS; STAPHYLOCOCCAL INFECTIONS; TIGECYCLINE;

EID: 84896481050     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813001325     Document Type: Article

References (16)

1. Carvalho KS, Mamizuka EM, Gontijo Filho PP. Methicillin/oxacillin- resistant Staphylococcus aureus as a hospital and public health threat in Brazil. Brazilian Journal of Infectious Diseases 2010; 14: 71-76.
2. Oliveira GA, et al. Characterization of the Brazilian endemic clone of methicilin-resistant Staphylococcus aureus (MRSA) from hospitals throughout Brazil. Brazilian Journal of Infectious Diseases 2001; 5: 163-170.
3. Schuenck RP, et al. Staphylococcus aureus isolates belonging to different multilocus sequence types present specific virulence gene profiles. FEMS Immunology & Medical Microbiology 2012; 65: 501-504.
4. Brazilian Health Surveillance Agency (ANVISA). (http://www.anvisa.gov.br/ servicosaude/controle/rede- rm/cursos/rm-controle/opas-web/modulo3/gramp- staphylo4.htm). Accessed 15 January 2013.
5. Bayer AS, Schneider T, Sahl HG. Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Annals of the New York Academy of Sciences 2013; 1277: 139-158.
6. McAleese F, et al. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratoryderived Staphylococcus aureus mutants to tigecycline. Antimicrobial Agents and Chemotherapy 2005; 49: 1865-1871.
7. Sader HS, Flamm RK, Jones RN. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011). Diagnostic Microbiology and Infectious Disease (in press).
8. Garza-González E, Dowzicky MJ. Changes in Staphylococcus aureus susceptibility across Latin America between 2004 and 2010. Brazilian Journal of Infectious Diseases 2013; 17: 13-19.
9. Zhanel GG, et al. Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study. Journal of Antimicrobial Chemotherapy 2013; 68 (Suppl. 1): i7-i22.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 20th Informational Supplement. CLSI document M100-S20. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute, 2010.
11. European Committee on Antimicrobial Susceptibility Testing. (http://www.eucast.org/fileadmin/src/media/ PDFs/EUCAST-files/Breakpoint-tables/ Breakpoint- table-v-2.0-120221.pdf). Accessed 15 January 2013.
12. Kondo Y, et al. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrobial Agents and Chemotherapy 2007; 51: 264-274.
13. Lina G, et al. Involvement of Panton-Valentine leukocidin- producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128-1132.
14. Enright MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillinsusceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008-1015.
15. Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233-2239.
16. Camargo IL, et al. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrobial Agents and Chemotherapy 2008; 52: 4289-4299.